Silva Pharmaceuticals Limited

DSE:SILVAPHL Stock Report

Market Cap: ৳1.3b

Silva Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Md. Ullah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure8.3yrs

Recent management updates

Recent updates

CEO

Md. Ullah

less than a year

Tenure

Mr. Md. Enayet Ullah is Chief Executive Officer and CC of Silva Pharmaceuticals Limited from 2025 and serves as its Director.

Board Members

NamePositionTenureCompensationOwnership
Md. Ullah
CEO, CC & Directorno datano datano data
Silvana Mirza
Chairman of the Board24.3yrs৳37.50kno data
Samina Mirza
Director24.3yrs৳75.00kno data
Farhana Mirza
Director24.3yrs৳28.13kno data
Monsur Rahman
Nominee Director8.3yrs৳84.38kno data
Muhammad Moniruzzaman
Independent Director5.2yrs৳46.88kno data
A. T. M. Sarrowar Chowdhury
Independent Director1.8yrs৳75.00kno data
A.K.M. Nuruzzaman
Directorless than a yearno datano data

8.3yrs

Average Tenure

42.5yo

Average Age

Experienced Board: SILVAPHL's board of directors are considered experienced (8.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 17:36
End of Day Share Price 2025/05/15 00:00
Earnings2025/03/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Silva Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.